<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Protein S-palmitoylation is markedly inhibited by 4″-alkyl ether lipophilic derivatives of EGCG, the major green tea polyphenol: In vitro and in silico studies</title>
				<funder ref="#_6hTNG5z">
					<orgName type="full">Department of Science and Technology-Science &amp; Engineering Research Board</orgName>
					<orgName type="abbreviated">SERB</orgName>
				</funder>
				<funder ref="#_cw8kQCU">
					<orgName type="full">Govt. of India</orgName>
				</funder>
				<funder ref="#_XemuV4B">
					<orgName type="full">unknown</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2023-12-16">16 December 2023</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Anupama</forename><surname>Binoy</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Chemistry</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manan</forename><surname>Kothari</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Chemistry</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Revathy</forename><surname>Sahadevan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Chemistry</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sayan</forename><surname>Poddar</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Biosciences and Biomedical Engineering</orgName>
								<orgName type="institution">Indian Institute of Technology Indore</orgName>
								<address>
									<addrLine>Madhya Pradesh 453552</addrLine>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Parimal</forename><surname>Kar</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Biosciences and Biomedical Engineering</orgName>
								<orgName type="institution">Indian Institute of Technology Indore</orgName>
								<address>
									<addrLine>Madhya Pradesh 453552</addrLine>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Sushabhan</forename><surname>Sadhukhan</surname></persName>
							<email>sushabhan@iitpkd.ac.in</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Chemistry</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="laboratory">Physical &amp; Chemical Biology Laboratory</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Biological Sciences &amp; Engineering</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Chemistry</orgName>
								<orgName type="institution">Indian Institute of Technology Palakkad</orgName>
								<address>
									<postCode>678623</postCode>
									<settlement>Kerala</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Protein S-palmitoylation is markedly inhibited by 4″-alkyl ether lipophilic derivatives of EGCG, the major green tea polyphenol: In vitro and in silico studies</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2023-12-16">16 December 2023</date>
						</imprint>
					</monogr>
					<idno type="MD5">B6CBBFAA43CEDBEFCAEB151FC4274704</idno>
					<idno type="DOI">10.1016/j.bbamem.2023.184264</idno>
					<note type="submission">Received 20 April 2023; Received in revised form 27 October 2023; Accepted 11 December 2023</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-06-12T11:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Green tea polyphenol EGCG Protein S-palmitoylation DHHC inhibitor Click reaction In silico analysis</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>S-palmitoylation is a dynamic lipid-based protein post-translational modification facilitated by a family of protein acyltransferases (PATs) commonly known as DHHC-PATs or DHHCs. It is the only lipid modification that is reversible, and this very fact uniquely qualifies it for therapeutic interventions through the development of DHHC inhibitors. Herein, we report that 4″-alkyl ether lipophilic derivatives of EGCG can effectively inhibit protein S-palmitoylation in vitro. With the help of metabolic labeling followed by copper(I)-catalyzed azidealkyne cycloaddition Click reaction, we demonstrate that 4″-C 14 EGCG and 4″-C 16 EGCG markedly inhibited Spalmitoylation in various mammalian cells including HEK 293T, HeLa, and MCF-7 using both in gel fluorescence as well as confocal microscopy. Further, these EGCG derivatives were able to attenuate the S-palmitoylation to the basal level in DHHC3-overexpressed cells, suggesting that they are plausibly targeting DHHCs. Confocal microscopy data qualitatively reflected spatial and temporal distribution of S-palmitoylated proteins in different sub-cellular compartments and the inhibitory effects of 4″-C 14 EGCG and 4″-C 16 EGCG were clearly observed in the native cellular environment. Our findings were further substantiated by in silico analysis which revealed promising binding affinity and interactions of 4″-C 14 EGCG and 4″-C 16 EGCG with key amino acid residues present in the hydrophobic cleft of the DHHC20 enzyme. We also demonstrated the successful inhibition of Spalmitoylation of GAPDH by 4″-C 16 EGCG. Taken together, our in vitro and in silico data strongly suggest that 4″-C 14 EGCG and 4″-C 16 EGCG can act as potent inhibitors for S-palmitoylation and can be employed as a complementary tool to investigate S-palmitoylation.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Protein S-palmitoylation is one of the most critical protein posttranslational modifications (PTMs) and the only protein lipidation that is reversible in nature. Herein, the cysteine side chains of target proteins get modified with the palmitoyl group via a labile thioester bond. It is a dynamic PTM that plays a critical role in cell health by regulating the subcellular localization, stability, membrane trafficking, and function of proteins <ref type="bibr" target="#b0">[1]</ref>. Protein S-palmitoylation is a prevalent PTM that affects almost 10% of the total human proteome highlighting its wide scope <ref type="bibr" target="#b1">[2]</ref>.</p><p>The addition of the palmitoyl group to proteins is facilitated by the writer enzymes, namely, protein palmitoyl acyltransferases (DHHC-PATs or, DHHCs) and deacylation is carried over by eraser enzymes called acyl protein thioesterases (APTs) (Fig. <ref type="figure" target="#fig_0">1a</ref>) <ref type="bibr" target="#b2">[3]</ref>. The writer enzyme, DHHCs, are conserved from yeast to humans and are so defined due to the presence of a highly conserved Asp-His-His-Cys (DHHC) catalytic domain <ref type="bibr" target="#b3">[4]</ref>. While, Schizosaccharomyces pombe (yeast) are known to possess five DHHC isoforms, the human genome encodes for twentythree isoforms of DHHCs designated as DHHC1 to DHHC24, omitting DHHC10 <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>. DHHCs are known to catalyze the addition of the palmitoyl group to the cysteine residues of the target protein via a twostep mechanism involving a transient acyl-intermediate via the autoacylation process <ref type="bibr" target="#b6">[7]</ref>. The emerging shreds of evidence demonstrate the involvement of DHHCs in normal as well as a number of diseased states including various types of cancer, metabolic diseases, neurodegenerative diseases, etc. <ref type="bibr" target="#b7">[8]</ref>. Critically important proteins such as Ras isoforms <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>, Src-related tyrosine kinases <ref type="bibr" target="#b10">[11]</ref>, epidermal growth factor receptor (EGFR) <ref type="bibr" target="#b11">[12]</ref>, subunits of G-protein and G-protein coupled receptors <ref type="bibr" target="#b12">[13]</ref>, rhodopsin <ref type="bibr" target="#b13">[14]</ref>, mammalian target of rapamycin (mTOR) <ref type="bibr" target="#b14">[15]</ref>, postsynaptic density-95 (PSD-95) <ref type="bibr" target="#b15">[16]</ref>, and synaptosomal-associated protein of 25 kDa (SNAP 25) <ref type="bibr" target="#b16">[17]</ref> are known to get Spalmitoylated. Protein S-palmitoylation has also been shown to play an instrumental role in the pathogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus by aiding the membrane fusion of viruses onto host cells <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>.</p><p>The reversible nature of S-palmitoylation which gives this lipid PTM a distinct identity from the other protein lipidation could be explored in developing therapeutic strategies to circumvent issues related to many diseases as mentioned above. There have been a handful of DHHC inhibitors reported to date which include certain lipid-based molecules such as 2-bromopalmitate (2-BP), cerulenin, and tunicamycin <ref type="bibr" target="#b22">[23]</ref>. While 2-BP (Fig. <ref type="figure" target="#fig_0">1b</ref>) is primarily known for inhibiting protein palmitoylation, it also has significant number of off-targets such as fatty acid synthase, carnitine palmitoyltransferase-1, acyl-CoA synthetase etc. <ref type="bibr" target="#b23">[24]</ref>. Ducker et al. reported a small molecule inhibitor compound V from a screen of 8000 compounds using an in situ imaging-based assay <ref type="bibr" target="#b24">[25]</ref>. Apart from that, very recently Qiu et al. reported the antimalarial natural product artemisinin to bind and inhibit zDHHC6 <ref type="bibr" target="#b25">[26]</ref>. Around the same time, Dickinson's group reported cyano-myracrylamide, a pan-DHHC inhibitor with comparable inhibitory effect to that of 2-BP <ref type="bibr" target="#b26">[27]</ref>. With the expansion of understanding the role and importance of DHHC-mediated biology, there also increases the urgent requirement for the identification of inhibitors for DHHCs. While there have been efforts in developing synthetic small molecule inhibitors for DHHCs, till now there is only one natural product-based DHHC inhibitor (Artemisinin). Natural product-based inhibitors have the added advantage of targeting the cancer cells preferably as compared to healthy non-cancerous cells.</p><p>(-)-Epigallocatechin-3-gallate (EGCG, Fig. <ref type="figure" target="#fig_0">1b</ref>), the major green tea polyphenol, is known for its enormous biological activities <ref type="bibr" target="#b27">[28]</ref>, including anti-obesity, anti-cancer, anti-inflammatory, immunomodulatory, anti-viral, and anti-oxidant activity, etc. Despite exhibiting such a wide array of biological activities, the use of EGCG in clinical trials is limited due to poor bioavailability, chemical instability, low membrane permeability, and rapid metabolism <ref type="bibr" target="#b27">[28]</ref>. We have previously synthesized a series of lipophilic derivatives of EGCG and successfully demonstrated its interaction with membrane-associated tyrosine kinase EGFR. Among the seven derivatives with varied lengths of alkyl chains, 4″-C 14 EGCG (Fig. <ref type="figure" target="#fig_0">1b</ref>) gave promising inhibition on EGFR activity. The underlying mechanism of inhibition of this derivative was attributed to the increased hydrophobicity of the molecule which facilitated its interaction with membrane proteins more effectively <ref type="bibr" target="#b28">[29]</ref>. A recent report by the Banerjee group revealed the crystal structure of zDHHC20 and zebrafish zDHHC15 explaining the details of the transmembrane and catalytic domains. The four transmembrane domains contributed to the formation of a cavity that accommodated the acyl chain of 2-BP <ref type="bibr" target="#b29">[30]</ref>. Here, for the first time, we demonstrate that the lipophilic derivative of EGCG namely, 4″-C 14 EGCG, and 4″-C 16 EGCG (Fig. <ref type="figure" target="#fig_0">1b</ref>) could inhibit the DHHC-mediated S-palmitoylation of proteins in vitro. With the help of metabolic labeling and copper-catalyzed Click chemistry (Fig. <ref type="figure" target="#fig_0">1c,</ref><ref type="figure">d</ref>) in the presence of alkynyl-tagged palmitic acid (Alk-14, Fig. <ref type="figure" target="#fig_0">1b</ref>), we observed that 4″-C 16 EGCG were effective in inhibiting the global S-palmitoylation in HEK 293T and 4″-C 14 EGCG as well as 4″-C 16 EGCG in case of MCF-7 and HeLa cells. Notably, 4″-C 16 EGCG significantly reduced the global palmitoylation protein profile to basal levels in DHHC3-overexpressing cells, which indicates the plausible effect of these molecules on the DHHC enzyme activity. The confocal images revealed the widely distributed spatial and temporal arrangement of Spalmitoylated proteins all over the cell especially on the lipid associated organelles. It also clearly exhibited the inhibition of metabolic labeling of Alk-14 in the presence of 4″-C 14 EGCG and 4″-C 16 EGCG and not with unmodified EGCG. Further, in silico molecular docking analysis of 4″-C 14 EGCG and 4″-C 16 EGCG with DHHC20 revealed better binding affinities for the aforementioned EGCG derivatives in comparison to the pan-DHHC inhibitor, 2-BP, or unmodified EGCG. The acyl chain of these lipophilic derivatives was found inserted into the hydrophobic cavity formed by the four transmembrane domains of the DHHC20. The hydrophobic and other non-covalent interactions found in the 2D interaction analysis showed that the catalytic C156 residue was closely posed to interact with EGCG. The molecular dynamics (MD) of the DHHC protein in each of the simulated complexes demonstrated a stable and nearly consistent RMSD pattern. Our pull-down experiment with GAPDH also demonstrated the inhibition of S-palmitoylation by 4″-C 16 EGCG. Taken together, our in vitro and in silico data show that 4″-C 14 EGCG and 4″-C 16 EGCG can effectively inhibit DHHC-mediated protein S-palmitoylation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and methods</head><p>(-)-Epigallocatechin-3-gallate (EGCG) was purchased from Carbosynth Ltd., UK, and Alkynyl palmitic acid (Alk-14) and carboxyrhodamine 110 azide were obtained from Click Chemistry Tools, USA. 2-Bromopalmitate, Protease inhibitor cocktail, DMSO, 2′,7′-dichlorofluorescein diacetate (DCFDA), CuSO 4 ⋅5H 2 O, tris(2-carboxyethyl) phosphine hydrochloride (TCEP) were procured from Sigma Aldrich while tris(benzyltriazolylmethyl)amine (TBTA) was obtained from Alfa Aesar. Coomassie brilliant blue R250 (CBB) (Sisco Research Laboratories), ECL reagent (Bio-Rad), 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) (TCI chemicals) were purchased from the commercial sources as mentioned in the parenthesis. Anti-HA and m-IgG Fc BP-HRP bundles were procured from Santa Cruz Biotechnology.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Chemical synthesis of 4″-alkyl ether lipophilic derivatives of EGCG</head><p>The 4″-alkyl ether lipophilic derivatives of EGCG with carbon chain length ranging from C 6 to C 18 (Fig. <ref type="figure" target="#fig_0">S1</ref>, ESI) were synthesized following the reported protocol from our group <ref type="bibr" target="#b28">[29]</ref>. All the compounds were purified, and thoroughly characterized as, mentioned earlier <ref type="bibr" target="#b28">[29]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Cell culture, treatment and transfection</head><p>Human cervical cancer cell line, HeLa, human breast cancer cell line, MCF-7, and human embryonic kidney cell line, HEK 293T were procured from the Cell Repository, National Center of Cell Science Pune, India, and were maintained as per the instructions. Cells were grown in complete Dulbecco's Modified Eagle's Medium (DMEM, HiMedia) media with 10% heat-inactivated fetal bovine serum (FBS, HiMedia), 1% Pen-Strep, and 0.2% Amphotericin (HiMedia). The cells were incubated in a humidified incubator at 37 • C with 5% CO 2 and were maintained according to the standard procedure in ATCC guidelines.</p><p>Cells were seeded with 0.6 × 10 6 cells per well in a 6-well cell culture plate and allowed to fix to the substratum overnight. Cells were pretreated with 4″-alkyl ether lipophilic derivatives of EGCG (50 μM) for 6 h and then incubated with 50 μM Alk-14 for another 6 h. All the stock preparation was done in 100% DMSO. DMSO concentration was maintained at &lt; 0.02% in all treatments. HA-tagged DHHC3 plasmids were transiently transfected in HEK 293T cells using calcium phosphate method <ref type="bibr" target="#b30">[31]</ref>. Transfection efficiency was analyzed through Western blotting and probing the proteins against anti-HA antibody.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Cell viability analysis</head><p>The cells (HeLa and MCF-7) were seeded at a cell density of 10,000 cells in each well and incubated for 24 h in the presence of various concentration ranging from 0 to 300 μM of 4″-alkyl ether lipophilic derivatives of EGCG (4″-C n EGCG, n = 6, 8, <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b17">18)</ref>. After the treatment, 10 μL of MTT (from a 5 mg/mL stock) was added into each well and the plate was incubated at 37 • C for further 2 h. The media was aspirated out carefully without disturbing the cells and the formazan crystals formed were dissolved in DMSO solvent (100 μL). The absorbance was recorded at 590 nm with 620 nm reference reading (for negating the background) using a BioTek EPOCH 2 plate reader. The IC 50 values were determined by generating a nonlinear regression curve fit using the GraphPad Prism 7 software. All experiments were performed in triplicates and the SEM was calculated from three independent experiments. The IC 50 values were represented as (mean ± SEM).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Visualization of global S-palmitoylation level via in gel fluorescence</head><p>Cells were treated as mentioned above in Section 2.2 and lysed thereafter using lysis buffer containing 1% NP-40 and protease inhibitor cocktail. 50 μg of proteins were incubated with a Click chemistry reaction mixture comprising 200 μM carboxyrhodamine 110 azide, 600 μM of TBTA, 2 mM of TCEP, and 2 mM of CuSO 4 for 1 h. The Clicked proteins were then precipitated by adding 200 μL ice-cold Methanol, 75 μL ice-cold CHCl 3 , and 150 μL ice-cold PBS to the Clicked samples. After a gentle agitation, the samples were centrifuged at 20,000g for 20 min at 4 • C. The upper aqueous phase was aspirated out carefully without disturbing the protein disk. The protein disk was allowed to settle down in the tube by adding another 1 mL of ice-cold methanol. The liquid phase was completely aspirated out without disturbing the protein pellet. The disk was then washed with 1 mL of methanol (ice cold) 3 times and subjected to air-dry. 4% SDS buffer was used to redissolve the precipitated protein before loading the samples into the SDS-PAGE. The proteins were denatured in 4X loading dye with 100 mM DTT at 95 • C for 10 min before resolving in 9% SDS-PAGE. The gel was destained overnight at 4 • C followed by swelling the gel in distilled water for half an hour. Further, the gel was analyzed for fluorescence signals at 525 nm in the Syngene G box.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">Qualitative analysis of metabolic labeling via confocal imaging upon the inhibitor treatments</head><p>Cells were grown on coverslips and treatment was conducted as mentioned above. After treatment cells were washed with 1X PBS thoroughly and fixed with 4% paraformaldehyde for 10 min at 4 • C. Further cells were washed in 1X PBS and permeabilized using 0.25% Triton X 100 in 1X PBS for 20 min and then blocked with 1% BSA in 1X PBS. The cells grown on coverslips were incubated to Click reaction master mix (100 μM carboxyrhodamine 110 azide, 100 μM TBTA, 1 mM CuSO 4, and 1 mM TCEP in 1 mL 1X PBS) for 1 h in dark at room temperature in shaking condition. The cells were further washed with 1X PBS and mounted over microscopic glass slides using 90% glycerol. The confocal images were acquired at 488 nm wavelength using Olympus FLUOVIEW FV3000. Laser power and exposure time were kept the same for all acquisition. Importantly, laser power and exposure time were first adjusted to acquire images for the samples treated with Alk-14 only, which were then fixed as default parameters for acquiring all other images for samples treated with EGCG derivatives. This allowed us to compare the difference in fluorescence intensities obtained in samples treated with 2-BP, 4″-C 14 EGCG and 4″-C 16 EGCG and with samples treated with Alk-14 alone.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6.">Western blotting</head><p>Treated cells were lysed and protein was estimated using the Bradford assay. The 50 μg proteins were denatured in 4X loading dye before resolving in 9% or 12% SDS-PAGE. The resolved proteins were transferred on the PVDF membrane and probed against an anti-HA antibody.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7.">Antioxidant assay</head><p>Total radical scavenging capacity of EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG were compared using a slightly modified version of the 2,2diphenyl-1-picryl-hydrazylhydrate (DPPH) assay technique <ref type="bibr" target="#b31">[32]</ref>. Briefly, 0.2 mM DPPH solution was prepared in 95% methanol. EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG stock solutions were made in concentration ranging from 1 μM -2 mM in DMSO. Finally, 50 μL of EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG stock solutions were diluted to a final concentration of 0.25-500 μM with 150 μL of DPPH solution in a 96-well plate and incubated in dark for 1.5 h at room temperature. The absorbance was recorded at a wavelength of 517 nm using a BioTek EPOCH 2 plate reader. The percentage of radical scavenging activity (RSA) was calculated using the equation:</p><formula xml:id="formula_0">%RSA = (A c -A s ) A c ×<label>100</label></formula><p>where, A s stands for absorbance of sample and A c for absorbance of control. IC 50 values for each of the compounds were estimated with nonlinear regression analysis using GraphPad Prism software.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.8.">DCFDA assay</head><p>ROS production by the EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG were assessed by using DCFDA probe. In brief, HeLa cells were treated with different concentrations of H 2 O 2 , EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG for 6 h. H 2 O 2 was taken as a positive control for ROS induction. The media was removed post-treatment and then replenished with fresh media containing 10 μM DCFDA and was incubated for 30 min in the dark at 37 • C. Then, the cells were washed with 1X PBS to remove excess DCFDA probe and fresh media was added. Fluorescence images were acquired at 488 nm/530 nm (ex/em wavelength) at 20X magnification using Olympus IX83.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9.">Docking studies and analysis</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9.1.">Protein preparations</head><p>The co-crystal structure of DHHC20 palmitoyltransferase with 2-BP <ref type="bibr" target="#b29">[30]</ref> (PDB ID: 6BML) was obtained from protein databank (www.rcsb. org) <ref type="bibr" target="#b32">[33]</ref>. The protein was prepared for docking in AutoDock v4.2 program <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35]</ref>. Chain B was deleted, as it does not interfere with the catalytic part of DHHCs. Water molecules, heteroatoms, and cocrystallized ligand were removed. Hydrogens and missing atoms were added, and Gasteiger charges were computed. The file was subsequently saved in pdbqt format and the protein was ready for docking.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9.2.">Ligand preparations</head><p>The structures of ligands were prepared in Avogadro <ref type="bibr" target="#b35">[36]</ref>, and energy was minimized. They were further converted to pdbqt files, which had atomic charges, atom definition for ligands, and topological information for docking using Open Babel GUI (openbabel.org) <ref type="bibr" target="#b36">[37]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9.3.">Docking studies using AutoDock Vina</head><p>The energy-minimized structure of the ligands were docked with DHHC20 using AutoDock Vina 1.1.2 <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b38">39]</ref>. The grid consisted of the active site and hydrophobic cleft with dimensions 16 Å × 28 Å × 68 Å centered in x, y, and z coordinates at 26.889, -49.583, and -42.333. These parameters were used to prepare an input file for AutoDock Vina.</p><p>Perl script was used to run the docking for all the molecules <ref type="bibr" target="#b39">[40]</ref>. The grid parameters were confirmed to be well established by docking 2-BP against the protein and comparing it with the covalently bound 2-BP. The best-docked structures with the highest binding affinity were visualized.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9.4.">Protein-ligand interaction studies</head><p>Biovia Discovery Studio 2021 software (Accelrys, San Diego, 2012) was used to investigate the 2-Dimension protein-ligand interactions for the docked molecules and the binding affinity values were compared. All the interactions, which comprised of hydrogen bonds, hydrophobic interaction, Van der Waals' interactions due to atom accessibilities, and other electrostatic interactions, were taken into consideration. Chimera X <ref type="bibr" target="#b40">[41]</ref> was used to visualize the protein surface based on hydrophobicity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.10.">Molecular dynamics studies</head><p>The PlayMolecule ProteinPrepare web application, which uses PROPKA 3.1 and PDB2PQR 2.1, was used to determine the protonation state and optimize the H-network for the structures <ref type="bibr" target="#b41">[42]</ref>. The molecular dynamics (MD) simulation was carried out using the pmemd.cuda module of the AMBER18 MD simulation package. The primary force field employed for the protein was ff14SB <ref type="bibr" target="#b42">[43]</ref>, while the General Amber Force Field (GAFF2) <ref type="bibr" target="#b43">[44]</ref> was used for modeling ligands. Within the protein, two zinc metal centers were present, consisting of four cysteines and one histidine amino acid surrounding the zinc ion. To prepare the system, the Zinc AMBER force field (ZAFF) was employed to handle the 4-coordinated zinc metal centers <ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref>. The atomic partial charges of the five ligands were determined using the AM1-BCC model using the antechamber module of amber <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b48">49]</ref>. The solvation of the complex structures utilized the TIP3P water model and a truncated octahedron periodic box extended at least 10 Å from the solute <ref type="bibr" target="#b49">[50]</ref>. Counterions were added as needed to neutralize the solvated system. Hydrogen bonds were constrained using the SHAKE algorithm, and temperature control at 300 K was achieved using the Langevin thermostat with a collision frequency of 2 ps -1 <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref>. Long-range electrostatic interactions were handled using the Particle-mesh Ewald (PME) scheme <ref type="bibr" target="#b53">[54]</ref>. The non-bonded cutoff was set to 10 Å. The solvated systems were energy minimized in two stages. In the first stage, all solute atoms of the system were restrained to their respective initial positions with force constant of 2 kcal mol -1 Å -2 , and the system was energy minimized by 500 steps of the steepest descent followed by another 500 steps of the conjugate gradient scheme. In the second stage, again each system was minimized using 500 steps of the steepest descent followed by 500 steps of conjugate gradient without positional constraints. Following the minimization, each system was heated from 0 to 300 K via MD simulation of 50 ps in the NVT ensemble using a 2 kcal mol -1 Å -2 restrain on the solute. Following this, all systems were equilibrated for 1.0 ns without any restraints. Finally, production MD simulations were conducted for 200 ns in the NPT ensemble at 300 K and 1 atm pressure. For trajectory analysis the cpptraj module of AmberTools19 was employed <ref type="bibr" target="#b67">[68]</ref>. The simulation was then followed by calculation of the binding free energy which was estimated using the molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) scheme <ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref>. A total of 5000 conformations from the last 100 ns of the trajectory were used to estimate the binding free energy.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.11.">Streptavidin pull-down experiment</head><p>HeLa cells were pretreated with 4″-C 16 EGCG, 2-BP and metabolically labelled with Alk-14 as described above. The protein concentration was determined for the whole lysates using Bradford reagent and 1 mg protein was subjected to Click reaction with biotin azide [biotin azide (200 μM), TBTA (600 μM), CuSO 4 (4 mM), and TCEP (4 mM)]. The Click reaction mixture was incubated at RT for 1 h with gentle shaking.</p><p>Proteins were then precipitated using ice-cold acetone at 20 • C for 1 h. The protein pellet was obtained by centrifuging at 10,000g for 15 min at 4 • C and was then solubilized with 0.2% SDS in 1X PBS using a water bath sonicator. The solubilized protein mixture was mixed with prewashed (0.2% SDS in 1X PBS, 2 washes) avidin beads and was incubated for 1.5 h at RT on a gyratory shaker. After the incubation, the beads were thoroughly washed with 1 mL 0.2% SDS in PBS (3 times), 1 mL 1X PBS (3 times), and finally with 1 mL Milli-Q H 2 O (3 times). Finally, 2X loading dye was added to the avidin beads and the mixture was boiled at 95 • C for 5 min. The supernatant was collected after centrifugation and equal volume were loaded on 12% SDS-PAGE gel and then the proteins were transferred to the PVDF membrane. The membrane was probed against anti GAPDH antibody.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.12.">Statistical analysis</head><p>All statistical analysis were performed employing GraphPad Prism 7 (San Diego, CA, USA). All the data were represented as mean ± standard error of the mean (SEM) from 3 independent experiments. The IC 50 values were obtained by performing non-linear regression analysis. Statistical differences were found using the one-way analysis of variance (ANOVA) with Dunnett's multiple comparisons test. The statistical significance was represented as 'ns' (non-significant) for p &gt; 0.05, * for p &lt; 0.05, ** for p &lt; 0.01, *** for p &lt; 0.001 and **** for p &lt; 0.0001.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results and discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">4″-C 14 EGCG and 4″-C 16 EGCG inhibit protein S-palmitoylation in HEK 293T, and HeLa cells</head><p>We have recently reported a series of lipophilic derivatives of EGCG with varied alkyl chains and among them, 4″-C 14 EGCG (Fig. <ref type="figure" target="#fig_0">1d</ref>) exhibited potent inhibition towards membrane-bound EGFR in various cancer cells. The affinity towards EGFR was attributed to the increased hydrophobicity of the alkyl chain. The native substrate of DHHCs, palmitoyl-CoA, also has a long hydrophobic chain which prompted us to think the presence of a long hydrophobic tail in 4″-C 14 EGCG and 4″-C EGCG can guide the EGCG derivatives into the catalytic pocket of DHHC and inhibit palmitoylation. Therefore, we went ahead and designed an experiment to check the effect of all 4″-alkyl ether lipophilic derivatives of EGCG (4″-C n EGCG, n = 6, 8, 10, 12, 14, 16, 18, Fig. <ref type="figure" target="#fig_0">S1</ref>, ESI) on the global S-palmitoylation profile. Briefly, cells were incubated in the presence of EGCG derivatives (50 μM) for 6 h followed by treatment with Alk-14 (50 μM) for another 6 h in the same media. The treated cells were lysed and the protein lysates were subjected to Click reaction with carboxyrhodamine 110 azide followed by an SDS-PAGE analysis. The in gel fluorescence images (Fig. <ref type="figure" target="#fig_1">2a</ref> and Fig. <ref type="figure" target="#fig_1">S2,</ref><ref type="figure">ESI</ref>) clearly demonstrate the marked inhibition of Alk-14 metabolic labeling in the presence of EGCG derivatives, namely 4″-C 16 EGCG for HEK 293 T cells, and 4″-C EGCG and 4″-C 16 EGCG for HeLa cells. A decrease in Alk-14 metabolic labeling indicated the inhibition of protein S-palmitoylation. It was noteworthy that inhibition of Alk-14 metabolic labeling by 4″-C 14 EGCG and 4″-C 16 EGCG was comparable to the inhibition induced by broad spectrum DHHC inhibitor 2-BP. Of note, EGCG alone was unable to show any inhibition and it is probably because of the lack of any directing group (long hydrophobic alkyl chain) present in it. We also conducted a cell viability analysis using the MTT assay for HeLa, and MCF-7 cell lines treated with various lipophilic derivatives of EGCG at various concentrations ranging from 1 to 300 μM. The IC 50 values from HeLa, and MCF-7 cell lines have been listed in Table <ref type="table" target="#tab_0">1</ref>. The lipophilic derivatives of EGCG with shorter acyl chains (4″-C 6 EGCG, 4″-C 8 EGCG) are found to be less toxic as compared to their longer acyl chain counterparts.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">4″-C 16 EGCG inhibits protein S-palmitoylation in DHHC3overexpressed HEK 293T cells</head><p>To get direct evidence on whether 4″-C 16 EGCG targets DHHC to reduce protein S-palmitoylation, we overexpressed HA-tagged DHHC3 in HEK 293T cells and analyzed the metabolic labeling of Alk-14 in the presence of 4″-C 16 EGCG. As expected, overexpression of DHHC3 resulted in an increase in Alk-14 labeling. Intriguingly, 4″-C 16 EGCG significantly alleviated the levels of DHHC-mediated S-palmitoylation and brought it to its basal level (Fig. <ref type="figure" target="#fig_1">2b</ref>). Banerjee's group in their seminal work on the structural aspects of DHHC have elucidated the mechanism of DHHC-mediated addition of palmitic acid to the substrate proteins via a two-step mechanism. The thiolate of the cysteine group at the active site of the enzyme, which resides on the membrane cytosol interphase, is known to transiently react with the long chain fatty acyl-CoAs to form an auto-acylated DHHC intermediate <ref type="bibr" target="#b29">[30]</ref>. In this conformation, the acyl chain lies embedded in the hydrophobic groove formed between Transmembrane 2 (TM2) and Transmembrane 3 (TM3) of the DHHC enzyme <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b57">58]</ref>. This fatty acyl chain is then transferred to the cysteine group present on the enzyme substrate <ref type="bibr" target="#b58">[59]</ref>. DHHCs have been implicated in playing essential role in a wide range of diseases, including cancers, neurodegenerative diseases, bacterial and viral infections etc. <ref type="bibr" target="#b59">[60]</ref>. Thus, it is noteworthy that the identification of DHHC inhibitors can be fruitful in combating life-threatening diseases. The alkyl chain present on the 4″-C 14 EGCG, and 4″-C 16 EGCG mimics the structure of palmitic acid, which further strengthen our hypothesis that suggest the plausibility of recognition of these alkyl chain by the hydrophobic cleft formed in the DHHC enzyme. This interaction can be considered as the main driving force for bringing the reported inhibitors in close proximity with the catalytic core of the DHHC enzyme.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">4″-C 14 EGCG and 4″-C 16 EGCG retain the innate biological activity of EGCG</head><p>Further, we wanted to examine whether the regioselective conjugation of alkyl chain at 4″ position of EGCG had any significant effects on the innate biological activity of EGCG namely, the prooxidant and antioxidant activities <ref type="bibr" target="#b60">[61]</ref>. To achieve this, we conducted DPPH assay to estimate the antioxidant activity and DCFDA staining to measure the intracellular levels of reactive oxygen species. The radical scavenging assay using DPPH radical (Fig. <ref type="figure" target="#fig_2">3a</ref> and<ref type="figure">b</ref>) clearly shows that the antioxidant activity of EGCG is retained after the modification at 4″ position. EGCG is also known to impart prooxidant effect in cancer cells <ref type="bibr" target="#b61">[62,</ref><ref type="bibr" target="#b62">63]</ref>. Thus, we went on to investigate the production of intracellular reactive oxygen species using DCFDA staining in EGCG, 4″-C 14 EGCG and 4″-C EGCG treated HeLa cells. The fluorescence images and relative fluorescence intensity graph (Fig. <ref type="figure" target="#fig_2">3c</ref> and<ref type="figure">d</ref>) further demonstrate that the addition of alkyl chains at 4″ position of EGCG did not compromise on the prooxidant activity of EGCG. Instead, these modifications have often substantiated the increased affinity and stability of these derivatives to lipid associated enzymes and receptors <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b63">64]</ref>.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">4″-C 14 EGCG and 4″-C 16 EGCG inhibit the global protein Spalmitoylation in cancer cells as revealed by Alk-14 labeling using confocal imaging</head><p>Protein S-palmitoylation has been implicated in the regulation of several oncogenes, including N-RAS, EGFR and tumor suppressor genes like SCRIB, melanocortin 1 receptor proteins <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b64">65,</ref><ref type="bibr" target="#b65">66]</ref>. Previous report from our lab successfully demonstrated that the 4″-C 14 EGCG has a potent anti-tumorigenic ability to specifically induce toxicity in cancer cells such as A431, HeLa and MCF-7 in comparison to EGCG <ref type="bibr" target="#b28">[29]</ref>. This prompted us to examine the effect of 4″-C 14 EGCG and 4″-C 16 EGCG treatment on the S-palmitoylation profile of cancer cells. The in gel fluorescence analysis in HeLa cells (Fig. <ref type="figure" target="#fig_1">S2</ref>, ESI) demonstrated that 4″-C 14 EGCG and 4″-C 16 EGCG were able to inhibit the S-palmitoylation levels of proteins. Further, we designed a confocal microscopy-based experiment wherein the HeLa and MCF-7 cells were treated with 2-BP, EGCG, 4″-C 12 EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG at a concentration of 50 μM for 6 h and then the cells were allowed to metabolically uptake Alk-14 for 6 h. The cells were then fixed with fixative and after permeabilization and blocking with BSA, they were subjected to Click reaction with carboxyrhodamine 110 azide. We observed that Spalmitoylation of proteins being a lipid based PTM, appeared to be uniformly distributed in all the membrane associated structures as well as other compartments in the cell which exemplifies the spatial and temporal existence of S-palmitoylated proteins in cancer cells. Moreover, it is noteworthy that DHHC enzymes are mostly found to be associated with endoplasmic reticulum, Golgi apparatus and the plasma membrane. Intriguingly, 4″-C 14 EGCG and 4″-C 16 EGCG were able to bring down this extensive palmitoylation of proteins to basal level in a similar fashion shown by 2-BP. Whereas, EGCG was unable to bring this effect (Fig. <ref type="figure" target="#fig_3">4a</ref>, b and Fig. <ref type="figure" target="#fig_2">S3</ref>, ESI). The biochemical and molecular level understanding of the S-palmitoylation inhibition induced by 4″-C 14 EGCG and 4″-C 16 EGCG with respect to their anticancer activity is under examination in our lab. Thus, we believe that the inhibition of S-palmitoylation by 4″-C 14 EGCG and 4″-C 16 EGCG may play an intriguing role in the suppression of carcinogenesis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5.">In silico studies reveal the interaction of 4″-C 14 EGCG and 4″-C 16 EGCG with DHHC20 active site</head><p>Careful analysis of the above results led us to hypothesize that the hydrophobicity of the long alkyl chain may play a critical role in decreasing the level of S-palmitoylation in different cell lines. Further, our in vitro studies prompted us to conduct an in silico analysis on the binding of 4″-C 12 EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG with DHHC20 enzyme, the only DHHC with resolved crystal structure from human origin. The binding score obtained for 4″-C 14 EGCG and 4″-C 16 EGCG against DHHC20 were found to be -7.9 and -8.0 kcal/mol, respectively (Fig. <ref type="figure" target="#fig_5">5a</ref>), which were better than the binding affinity of 2-BP (-6.8 kcal/ mol), a known pan inhibitor of DHHC enzymes. The binding affinity value obtained for 4″-C 12 EGCG (-7.5 kcal/mol) was lower than the longer alkyl chain derivatives, suggesting their higher extent of interaction. The best docking confirmations revealed that the acyl chain of 4″-C 14 EGCG (Fig. <ref type="figure" target="#fig_5">5h,</ref><ref type="figure">i</ref>, and Fig. <ref type="figure" target="#fig_3">S4</ref>, ESI) and 4″-C 16 EGCG (Fig. <ref type="figure" target="#fig_5">5j,</ref><ref type="figure">k</ref>, and Fig. <ref type="figure" target="#fig_5">S5,</ref><ref type="figure">ESI</ref>) was embedded inside the hydrophobic cavity formed in between the TM2 and TM3 in a very similar way to how the acyl chain of 2-BP was lying inside the cavity (Fig. <ref type="figure" target="#fig_5">5b,</ref><ref type="figure">c</ref>, and Fig. <ref type="figure" target="#fig_6">S6,</ref><ref type="figure">ESI</ref>). When the docking confirmations of EGCG alone were compared with 4″-C 12 EGCG (Fig. <ref type="figure" target="#fig_5">5f,</ref><ref type="figure">g</ref>  The in silico 2-D interaction studies also revealed that the acyl chain of the 4″-C 14 EGCG and 4″-C 16 EGCG were interacting non-covalently (π-alkyl, hydrogen bonding, Van der Waals forces', etc.) with several amino acids, particularly W158 and F171 which are involved in constricting the hydrophobic cavity of the enzyme. Additionally, F174 and L227 were also found to be interacting with the acyl chain. The noncovalent and hydrophobic interaction with these amino acids suggests  that the acyl chain was stabilized inside the hydrophobic cavity (Fig. <ref type="figure" target="#fig_6">6</ref> and Table <ref type="table" target="#tab_1">2</ref>). Although 4″-C 12 EGCG shows interactions with DHHC20, they were predominantly of Van der Waals type, which suggested lower extent of interaction in case of 4″-C 12 EGCG as compared to our longer chain alkyl ether derivatives consisting of 14 and 16 carbons, respectively. Taken together, the molecular docking analysis of the interactions between the longer chain alkyl ether derivatives and DHHC20 suggest greater propensity of inhibition.</p><p>Table <ref type="table" target="#tab_0">S1</ref> and Fig. <ref type="figure" target="#fig_6">6</ref> summarizes the similarity in overall interactions between 2-BP/DHHC20 compared to 4″-C 12 EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG/DHHC20. Moreover, H154 present on the catalytic site which aids in the nucleophilic attack on the cysteine <ref type="bibr" target="#b29">[30]</ref> was found to make interactions such as hydrogen bonds and π cation with EGCG molecule in its alkyl ether derivatives. All these shreds of evidence strongly suggest that the interactions between the alkyl chain and amino acid residues housing the hydrophobic cleft are the driving force in bringing the electrophilic group on EGCG in close proximity to the reactive cysteine present in the catalytic site of DHHC enzyme.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6.">Protein dynamics simulation 3.6.1. Dynamics of DHHC protein-ligand complexes</head><p>The analysis of the DHHC protein's dynamics in each of the five simulated complexes was conducted by examining the root mean square deviation (RMSD) of the backbone residues (N, C, and C α atoms). Across all complexes, the protein demonstrated a stable and nearly consistent pattern throughout the simulation period, as illustrated in Fig. <ref type="figure" target="#fig_7">7</ref>. While there was a minor RMSD deviation in the case of the 2-BP bound complex after 100 ns, this deviation stabilized after 150 ns (Fig. <ref type="figure" target="#fig_7">7</ref>). The majority of fluctuations in RMSD can be primarily attributable to the protein's loops. Overall, in all systems, there was no significant degradation or substantial changes in the protein's conformation observed.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6.2.">Free energy contribution</head><p>In addition to studying the dynamics, we conducted an analysis of the binding strength between the ligand and the DHHC protein. To achieve this, we utilized the MM/PBSA approach to calculate the binding enthalpy and individual energy components associated with the interaction between the protein and ligands. The complete binding enthalpy and its components are listed in Table <ref type="table">3</ref> and visualized in Fig. <ref type="figure" target="#fig_8">8</ref>. The energy calculation shows that 4″-C 14 EGCG (-45.35 ± 0.07 kcal/mol), and 4″-C 16 EGCG (-49.39 ± 0.07 kcal/mol) exhibit better binding free energy values compared to the control 2-BP (-34.36 ± 0.06 kcal/mol), which aligns with experimental findings. Experimental results indicate that EGCG fails to exert any inhibitory effect, indicating its low affinity for binding to the protein. This observation aligns with the simulation results, which demonstrate a very low binding affinity for EGCG (-10.19 ± 0.06 kcal/mol). Upon closer examination of the contributions from different forces, it becomes evident that the net electrostatic component, which is the combined effect of electrostatic (ΔE elec ) and polar solvation free energy (ΔG pol ) was unfavorable towards ligand binding. Overall, the Van der Waals (ΔE vd w ) forces predominantly govern the binding process.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.7.">4″-C 16 EGCG inhibits the S-palmitoylation of glyceraldehyde 3phosphate dehydrogenase (GAPDH) protein</head><p>To confirm if 4″-C 16 EGCG inhibits acylation of proteins, we  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 3</head><p>Free energy components values (kcal/mol) for DHHC20-ligand complexes. Data are represented as average ± SEM.  <ref type="bibr" target="#b68">[69]</ref>. Interestingly, we were able to successfully observe a decrease in GAPDH pull down in protein lysates obtained from metabolically labelled HeLa cells pretreated with 4″-C 16 EGCG comparison to Alk-14 treatment alone (Fig. <ref type="figure" target="#fig_9">9</ref>). These results validate our findings that 4″-C 16 EGCG can inhibit the S-palmitoylation of endogenous proteins.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Conclusion</head><p>Protein S-palmitoylation is mediated by writer and eraser enzymes, known as DHHCs and APTs respectively. The reversible nature of this modification uniquely qualifies it for the development of therapeutical strategies to combat different pathophysiological conditions. Among the very few known inhibitors of DHHC, 2-BP has been widely used. However, it is known for its off-targets including fatty acid synthase, carnitine palmitoyltransferase-1, acyl-CoA synthetase etc. Thus, there is a pressing demand to identify potent DHHC inhibitors. This study explores the potential of EGCG, an active polyphenol found in the green tea to inhibit the S-palmitoylation of proteins by introducing structural modifications in it. The global S-palmitoylation level of proteins were inhibited by 4″-C 16 EGCG in HEK 293T cells whereas both 4″-C 14 EGCG, and 4″-C 16 EGCG inhibited the protein palmitoylation in HeLa cells. 4″-C 16 EGCG effectively inhibited the S-palmitoylation in DHHC3overexpressing HEK 293T cells. Our confocal data provided an insightful view on the extensive and widely distributed spatial and temporal arrangement of S-palmitoylated proteins in cancer cells such as HeLa and MCF-7 cells, and further showed the efficacy of 4″-C 14 EGCG, and 4″-C 16 EGCG in inhibiting protein S-palmitoylation. Both 4″-C 14 EGCG, and 4″-C 16 EGCG reduced the levels of S-palmitoylation of proteins to the basal levels. Our in-silico analysis successfully exhibited high binding affinity of 4″-C 14 EGCG, and 4″-C 16 EGCG towards DHHC20. The driving force for these interactions was mainly associated with the positioning of alkyl chain into the hydrophobic cleft formed by the transmembrane domains of the enzyme. The alkyl chain was seen to form various noncovalent interactions with important amino residues present inside the hydrophobic cleft of the enzyme. These interactions were mainly responsible for bringing the EGCG part of the inhibitors in close proximity to the catalytic cysteine in the enzyme. In fact, our molecular dynamics simulations also suggested that Van der Waals forces accounted for major part of binding affinity values obtained. We were also able to show that 4″-C 16 EGCG was also able to inhibit the S-palmitoylation of GAPDH protein. Taken together, our in vitro and in silico data strongly support the inhibitory effect of 4″-C 14 EGCG, and 4″-C 16 EGCG against DHHC enzymes, and they can act as a complimentary tool to investigate protein S-palmitoylation.</p><p>CRediT authorship contribution statement S.S. conceived and supervised the study; A.B., M.K., and R.S performed experiments and data analysis; S.P. and P.K. performed the MD simulation studies; all the authors wrote the manuscript.  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Fig. 1. a) Schematic representation of protein S-palmitoylation. b) Chemical structures of 2-BP, Alk-14, EGCG, 4″-C 14 EGCG, and 4″-C 16 EGCG. c) Cellular process of palmitoylation where palmitic acid gets converted to palmitoyl-CoA and then is attached to the protein of interest (POI) with the help of DHHCs. d) Application of metabolic labeling with Alk-14 and Click reaction to study protein S-palmitoylation. Carboxyrhodamine 110 azide is denoted by Rh-N 3 .</figDesc><graphic coords="2,42.15,383.58,510.24,323.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc>Fig. 2. Inhibition of protein S-palmitoylation by 4″-alkyl ether derivatives of EGCG. a) In gel fluorescence image depicting the inhibition of global metabolic labeling of Alk-14 when HEK 293T cells were incubated with 4″-alkyl ether lipophilic derivatives of EGCG (4″-C n EGCG, n = 6, 8, 10, 12, 14, 16, 18) in vitro. b) In gel fluorescence image depicting the inhibition of global metabolic labeling of Alk-14 in DHHC3 overexpressed HEK 293T cells in the presence of 4″-C 16 EGCG.</figDesc><graphic coords="5,67.15,432.53,460.53,274.54" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc>Fig. 3. Comparison of biological activity of 4″-C 14 EGCG and 4″-C 16 EGCG with EGCG. a) A non-linear regression analysis graph exhibiting the radical scavenging ability of 4″-C 14 EGCG, 4″-C 16 EGCG and EGCG in dose dependent manner as obtained in DPPH assay. b) Bar plot comparing the IC 50 of 4″-C 14 EGCG, 4″-C 16 EGCG and EGCG obtained from DPPH assay. *** denotes p value &lt; 0.0001. c) Fluorescence image depicting the induction of reactive oxygen species in 4″-C 14 EGCG, 4″-C EGCG and EGCG treated HeLa cell lines for 6 h. The intracellular ROS generation was measured by staining the cells with cell permeable DCFDA stain. d) Relative fluorescence intensity bar diagram quantifying the levels of ROS induced in each image shown in Fig. 3d where ns denotes p &gt; 0.05.</figDesc><graphic coords="6,41.64,401.43,511.64,286.54" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4 .</head><label>4</label><figDesc>Fig. 4. Qualitative analysis of global metabolic labeling of Alk-14 in the presence of 4″-C 12 EGCG, 4″-C 14 EGCG and 4″-C 16 EGCG. Confocal image analysis of global metabolic labeling of Alk-14 in a) HeLa cells and b) MCF-7 cells treated with 2-BP (50 μM), 4″-C 12 EGCG (50 μM), 4″-C 14 EGCG (50 μM), 4″-C 16 EGCG (50 μM), and EGCG (50 μM).</figDesc><graphic coords="7,48.64,395.10,497.52,312.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>hydrophobic chain present in alkyl derivatives of EGCG and 2-BP assisted the molecules to come closer to active site C156 by mimicking the structure of fatty acyl CoAs (Fig. S10, ESI).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 5 .</head><label>5</label><figDesc>Fig. 5. Docking results reveal effective interactions of 4″-C 14 EGCG and 4″-C 16 EGCG with DHHC20. a) A bar graph displaying binding energies of 4″-C 16 EGCG and 4″-C 14 EGCG in comparison to 4″-C 12 EGCG, 2-BP and EGCG. b-k) Ribbon representation of hydrophobic cleft as seen in Discovery Studio and Chimera X analysis images showing the positioning of 2-BP (b, c), EGCG (d, e), 4″-C 12 EGCG (f, g), 4″-C 14 EGCG (h, i), and 4″-C 16 EGCG (j, k). In the Chimera X images, hydrophobic pocket has been coded brown in color whereas hydrophilic region is represented in blue color. The catalytic residue, C156 is highlighted in green color.</figDesc><graphic coords="8,41.64,55.53,511.65,289.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 6 .</head><label>6</label><figDesc>Fig. 6. 2-D docking interaction of amino acid residues in the hydrophobic cavity of DHHC20 and the acyl chain of a) 2-BP, b) 4″-C 12 EGCG, d) 4″-C 14 EGCG and e) 4″-C 16 EGCG. c) Amino acids interacting with EGCG near the catalytic domain of DHHC20.</figDesc><graphic coords="8,41.64,478.60,511.64,238.06" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig. 7 .</head><label>7</label><figDesc>Fig. 7. Time evolution of RMSD profile of DHHC20 bound with different ligands.</figDesc><graphic coords="9,174.19,487.71,246.72,131.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 8 .</head><label>8</label><figDesc>Fig. 8. Free energy components (kcal/mol) for DHHC protein-ligand complexes. ΔE vdw , Van der Waals energy; ΔE ele , electrostatic energy; ΔG polar , polar solvation energy; ΔG np , non-polar solvation energy; ΔH bind , enthalpy.</figDesc><graphic coords="10,126.65,56.20,341.52,182.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig. 9 .</head><label>9</label><figDesc>Fig. 9. Immuno-blotting with anti-GAPDH antibody on the streptavidin enriched samples after the whole lysates obtained from metabolically labelled HeLa cells pretreated with 4″-C 16 EGCG were Clicked with biotin azide. β actin was added here to show equal amount of proteins were taken for streptavidin enrichment after Click reaction with biotin azide.</figDesc><graphic coords="10,174.19,286.69,246.72,99.84" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>IC 50 values of EGCG and all the 4″-alkyl ether lipophilic derivatives of EGCG in HeLa and MCF-7 cells as measured by the MTT assay. The IC 50 values are expressed as (mean ± SEM).</figDesc><table><row><cell>Compounds</cell><cell>IC 50 (μM)</cell><cell></cell></row><row><cell></cell><cell>HeLa</cell><cell>MCF-7</cell></row><row><cell>4″-C 6 EGCG</cell><cell>140.10 ± 1.06</cell><cell>129.30 ± 1.96</cell></row><row><cell>4″-C 8 EGCG</cell><cell>138.80 ± 1.05</cell><cell>121.50 ± 1.03</cell></row><row><cell>4″-C 10 EGCG</cell><cell>105.30 ± 0.09</cell><cell>106.40 ± 1.05</cell></row><row><cell>4″-C 12 EGCG</cell><cell>103.20 ± 1.10</cell><cell>119.20 ± 1.03</cell></row><row><cell>4″-C 14 EGCG</cell><cell>82.36 ± 1.04</cell><cell>93.28 ± 1.02</cell></row><row><cell>4″-C 16 EGCG</cell><cell>100.20 ± 1.04</cell><cell>112.50 ± 1.05</cell></row><row><cell>4″-C 18 EGCG</cell><cell>107.10 ± 1.03</cell><cell>119.90 ± 1.02</cell></row><row><cell>EGCG</cell><cell>58.32 ± 0.99</cell><cell>63.51 ± 1.22</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc>List of interactions exhibited by 2-BP, 4″-C 12 EGCG, 4″-C 14 EGCG, 4″-C 16 EGCG, and EGCG with critical amino acids present in the hydrophobic cleft of DHHC20.</figDesc><table><row><cell>Compound name</cell><cell>Binding energy (kcal/mol)</cell><cell></cell><cell></cell><cell cols="2">Type of interaction with critical amino acids</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H154</cell><cell>C156</cell><cell>W158</cell><cell>F171</cell><cell>F174</cell><cell>L227</cell></row><row><cell>2-BP</cell><cell>-6.8</cell><cell>-</cell><cell>H-bond</cell><cell>Van der Waals</cell><cell>Van der Waals</cell><cell>π-Alkyl</cell><cell>-</cell></row><row><cell>4″-C 12 EGCG</cell><cell>-7.5</cell><cell>Van der Waals</cell><cell>Van der Waals</cell><cell>Pi-Pi T-shaped &amp; Pi-alkyl</cell><cell>Van der Waals</cell><cell>Pi-alkyl</cell><cell>Pi-sigma &amp; Pi-alkyl</cell></row><row><cell>4″-C 14 EGCG</cell><cell>-7.9</cell><cell>H-bond</cell><cell>H-bond &amp; π-alkyl</cell><cell>π-Alkyl</cell><cell>Van der Waals</cell><cell>π-Alkyl</cell><cell>π-Alkyl</cell></row><row><cell>4″-C 16 EGCG</cell><cell>-8.0</cell><cell>H-bond &amp; π-cation</cell><cell>H-bond &amp; π-alkyl</cell><cell>H-bond &amp; π -alkyl</cell><cell>Van der Waals</cell><cell>π-Alkyl</cell><cell>Van der Waals</cell></row><row><cell>EGCG</cell><cell>-6.7</cell><cell>Van der Waals</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>-</cell></row></table></figure>
		</body>
		<back>

			<div type="funding">
<div><head>Funding statement and acknowledgement</head><p>The authors gratefully acknowledge the financial support from the <rs type="funder">Department of Science and Technology-Science &amp; Engineering Research Board (DST-SERB), Govt. of India</rs> (<rs type="grantNumber">ECR/2017/002082</rs>, <rs type="grantNumber">PDF/2020/ 001950</rs>) and <rs type="institution">Council of Scientific &amp; Industrial Research (CSIR)</rs>, <rs type="funder">Govt. of India</rs> (<rs type="grantNumber">02(0434)/21/EMR-II, 09/1282(0003</rs>)/2019-EMR-I). We are thankful to <rs type="person">Prof. Hening Lin</rs>, <rs type="affiliation">Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14850, United States</rs> for his generous help with the DHHC3 plasmid.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_6hTNG5z">
					<idno type="grant-number">ECR/2017/002082</idno>
				</org>
				<org type="funding" xml:id="_cw8kQCU">
					<idno type="grant-number">PDF/2020/ 001950</idno>
				</org>
				<org type="funding" xml:id="_XemuV4B">
					<idno type="grant-number">02(0434)/21/EMR-II, 09/1282(0003</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability</head><p>Data will be made available on request.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Declaration of competing interest</head><p>The authors declare that there is no conflict of interest.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix A. Supplementary data</head><p>Supplementary data to this article can be found online at https://doi. org/10.1016/j.bbamem.2023.184264.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Protein palmitoylation and cancer</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Dixon</surname></persName>
		</author>
		<idno type="DOI">10.15252/embr.201846666</idno>
		<ptr target="https://doi.org/10.15252/embr.201846666" />
	</analytic>
	<monogr>
		<title level="j">EMBO Rep</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">46666</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">SwissPalm 2: protein S-palmitoylation database</title>
		<author>
			<persName><forename type="first">M</forename><surname>Blanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P A</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Van Der Goot</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-1-4939-9532-5_16</idno>
		<ptr target="https://doi.org/10.1007/978-1-4939-9532-5_16" />
	</analytic>
	<monogr>
		<title level="j">Methods Mol. Biol</title>
		<imprint>
			<biblScope unit="page" from="203" to="214" />
			<date type="published" when="2009">2009. 2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rusch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bürger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Dekke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Görmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Triola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brockmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Janning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Böttcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Sieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Vetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hedberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Waldmann</surname></persName>
		</author>
		<idno type="DOI">10.1002/anie.201102967</idno>
		<ptr target="https://doi.org/10.1002/anie.201102967" />
	</analytic>
	<monogr>
		<title level="j">Angew. Chem. Int. Ed</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="9838" to="9842" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Greentree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deschenes</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m206573200</idno>
		<ptr target="https://doi.org/10.1074/jbc.m206573200" />
	</analytic>
	<monogr>
		<title level="j">JBC</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="41268" to="41273" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Protein palmitoylation by a family of DHHC protein S-acyltransferases</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vasudevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deschenes</surname></persName>
		</author>
		<idno type="DOI">10.1194/jlr.r600007-jlr200</idno>
		<ptr target="https://doi.org/10.1194/jlr.r600007-jlr200" />
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1118" to="1127" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Analysis of substrate specificity of human DHHC protein acyltransferases using a yeast expression system</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kashio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ogata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ishitomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kihara</surname></persName>
		</author>
		<idno type="DOI">10.1091/mbc.e12-05-0336</idno>
		<ptr target="https://doi.org/10.1091/mbc.e12-05-0336" />
	</analytic>
	<monogr>
		<title level="j">Mol. Biol. Cell</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="4543" to="4551" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Insights into auto-S-fatty acylation: Targets, druggability, and inhibitors</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1039/d1cb00115a</idno>
		<ptr target="https://doi.org/10.1039/d1cb00115a" />
	</analytic>
	<monogr>
		<title level="j">Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1567" to="1579" />
			<date type="published" when="2021">2021</date>
			<publisher>RSC</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Emerging roles of DHHC-mediated protein S-palmitoylation in physiological and pathophysiological context</title>
		<author>
			<persName><forename type="first">I</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sadhukhan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejcb.2018.03.005</idno>
		<ptr target="https://doi.org/10.1016/j.ejcb.2018.03.005" />
	</analytic>
	<monogr>
		<title level="j">Eur. J. Cell Biol</title>
		<imprint>
			<biblScope unit="page" from="319" to="338" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Tarpey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Edkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tofts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>O'meara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Teague</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barthorpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Buck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Halliday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hinton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Menzies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Raine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shepherd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Varian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Widaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Mallya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Quarrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wooste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bobrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gecz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1086/513609</idno>
		<ptr target="https://doi.org/10.1086/513609" />
	</analytic>
	<monogr>
		<title level="m">Mutations in ZDHHC9</title>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="982" to="987" />
		</imprint>
	</monogr>
	<note>which</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Swarthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Farh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Croke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Greentree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deschenes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Linder</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m504113200</idno>
		<ptr target="https://doi.org/10.1074/jbc.m504113200" />
	</analytic>
	<monogr>
		<title level="m">DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H-and N-Ras</title>
		<imprint>
			<date type="published" when="2005">2005</date>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="31141" to="31148" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif</title>
		<author>
			<persName><forename type="first">M</forename><surname>Koegl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zlatkine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Ley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Courtneidge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Magee</surname></persName>
		</author>
		<idno type="DOI">10.1042/bj3030749</idno>
		<ptr target="https://doi.org/10.1042/bj3030749" />
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="749" to="753" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Inhibition of DHHC20-Mediated EGFR palmitoylation creates a dependence on EGFR signaling</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Runkle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kharbanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stypulkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Witze</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.molcel.2016.04.003</idno>
		<ptr target="https://doi.org/10.1016/j.molcel.2016.04.003" />
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="385" to="396" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Role of palmitoylation/depalmitoylation reactions in Gprotein-coupled receptor function</title>
		<author>
			<persName><forename type="first">R</forename><surname>Qanbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bouvier</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0163-7258(02)00300-5</idno>
		<idno>0163-7258(02)00300-5</idno>
		<ptr target="https://doi.org/10.1016/s" />
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Ther</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1" to="33" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Palmitoylation of rhodopsin with S-protein acyltransferase: enzyme catalyzed reaction versus autocatalytic acylation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Veit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heckelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Maretzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Schmidt</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0005-2760(98)00097-6</idno>
		<ptr target="https://doi.org/10.1016/s0005-2760(98)00097-6" />
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1394</biblScope>
			<biblScope unit="page" from="90" to="98" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">mTORC1 signaling is palmitoylationdependent in hippocampal neurons and non-neuronal cells and involves dynamic palmitoylation of LAMTOR1 and mTOR</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">I</forename><surname>De Simone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="DOI">10.3389/fncel.2019.00115</idno>
		<ptr target="https://doi.org/10.3389/fncel.2019.00115" />
	</analytic>
	<monogr>
		<title level="j">Front. Cell. Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">115</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Identification of PSD-95 palmitoylating enzymes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fukata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adesnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Nicoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Bredt</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2004.12.005</idno>
		<ptr target="https://doi.org/10.1016/j.neuron.2004.12.005" />
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="987" to="996" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Palmitoylation of the SNAP25 protein family: specificity and regulation by DHHC palmitoyl transferases</title>
		<author>
			<persName><forename type="first">J</forename><surname>Greaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Gorleku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Salaun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chamberlain</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m110.119289</idno>
		<ptr target="https://doi.org/10.1074/jbc.m110.119289" />
	</analytic>
	<monogr>
		<title level="j">JBC</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="24629" to="24638" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry</title>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1002/jmv.27339</idno>
		<ptr target="https://doi.org/10.1002/jmv.27339" />
	</analytic>
	<monogr>
		<title level="j">J. Med. Virol</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="342" to="348" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNAdependent RNA polymerase (RdRp) inhibition: an in-silico analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fulbabu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sonawane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kar</surname></persName>
		</author>
		<author>
			<persName><surname>Sadhukhan</surname></persName>
		</author>
		<idno type="DOI">10.1080/07391102.2020.1796810</idno>
		<ptr target="https://doi.org/10.1080/07391102.2020.1796810" />
	</analytic>
	<monogr>
		<title level="j">J. Biomol. Struct. Dyn</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="6249" to="6264" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Glycosylation and Spalmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Tien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Ping</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Yu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.isci.2022.104709</idno>
		<ptr target="https://doi.org/10.1016/j.isci.2022.104709" />
	</analytic>
	<monogr>
		<title level="j">iScience</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page">104709</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41392-021-00651-y</idno>
		<ptr target="https://doi.org/10.1038/s41392-021-00651-y" />
	</analytic>
	<monogr>
		<title level="m">Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity</title>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">231</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Deep</surname></persName>
		</author>
		<idno type="DOI">10.1080/07391102.2020.1844058</idno>
		<ptr target="https://doi.org/10.1080/07391102.2020.1844058" />
	</analytic>
	<monogr>
		<title level="j">J. Biomol. Struct. Dyn</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="3003" to="3010" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Palmitoyl acyltransferase assays and inhibitors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1080/09687680802683839</idno>
		<ptr target="https://doi.org/10.1080/09687680802683839" />
	</analytic>
	<monogr>
		<title level="j">Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="5" to="13" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Profiling targets of the irreversible palmitoylation inhibitor 2-bromopalmitate</title>
		<author>
			<persName><forename type="first">D</forename><surname>Davda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>El Azzouny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Tom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Majmudar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1021/cb400380s</idno>
		<ptr target="https://doi.org/10.1021/cb400380s" />
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1912" to="1917" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Discovery and characterization of inhibitors of human palmitoyl acyltransferases</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ducker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Griffel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">X</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Diller</surname></persName>
		</author>
		<idno type="DOI">10.1158/1535-7163.mct-06-0114</idno>
		<ptr target="https://doi.org/10.1158/1535-7163.mct-06-0114" />
	</analytic>
	<monogr>
		<title level="j">Mol. Cancer Ther</title>
		<imprint>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1647" to="1659" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6</title>
		<author>
			<persName><forename type="first">N</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Abegg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gilmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Seeberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Adibekian</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.chembiol.2021.07.012</idno>
		<ptr target="https://doi.org/10.1016/j.chembiol.2021.07.012" />
	</analytic>
	<monogr>
		<title level="j">Cell Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="530" to="537" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Development of an acrylamide-based inhibitor of protein S-acylation</title>
		<author>
			<persName><forename type="first">S.-A</forename><surname>Azizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delalande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kathayat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Mejia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Brookes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Sandoval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Dickinson</surname></persName>
		</author>
		<idno type="DOI">10.1021/acschembio.1c00405</idno>
		<ptr target="https://doi.org/10.1021/acschembio.1c00405" />
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1546" to="1556" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Chemico-biological aspects of (-)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: current status and future prospects</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sahadevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Binoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sadhukhan</surname></persName>
		</author>
		<idno type="DOI">10.1080/10408398.2022.2068500</idno>
		<ptr target="https://doi.org/10.1080/10408398.2022.2068500" />
	</analytic>
	<monogr>
		<title level="j">Crit. Rev. Food Sci. Nutr</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="10382" to="10411" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Structure-based design and synthesis of a novel long-chain 4″-alkyl ether derivative of EGCG as potent EGFR inhibitor: in vitro and in silico studies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sahadevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Biswas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sonawane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sadhukhan</surname></persName>
		</author>
		<idno type="DOI">10.1039/d2ra01919a</idno>
		<ptr target="https://doi.org/10.1039/d2ra01919a" />
	</analytic>
	<monogr>
		<title level="j">RSC Adv</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="17821" to="17836" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Fatty acyl recognition and transfer by an integral membrane S-acyltransferase</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Rana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Verardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Rajashanka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.aao6326</idno>
		<ptr target="https://doi.org/10.1126/science.aao6326" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="page">6326</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">DNA transfection: calcium phosphate method</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Firestein</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-1-62703-444-9_10</idno>
		<ptr target="https://doi.org/10.1007/978-1-62703-444-9_10" />
	</analytic>
	<monogr>
		<title level="j">Methods Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">1018</biblScope>
			<biblScope unit="page" from="107" to="110" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Comparison of in vitro antioxidant and antiradical activities of L-tyrosine and L-Dopa</title>
		<author>
			<persName><forename type="first">I</forename><surname>Gülçin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00726-006-0379-x</idno>
		<ptr target="https://doi.org/10.1007/s00726-006-0379-x" />
	</analytic>
	<monogr>
		<title level="j">Amino Acids</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="431" to="438" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The protein data bank and the challenge of structural genomics</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Berman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Bhat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Bournem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gilliland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Weissig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Westbrook</surname></persName>
		</author>
		<idno type="DOI">10.1038/80734</idno>
		<ptr target="https://doi.org/10.1038/80734" />
	</analytic>
	<monogr>
		<title level="j">Nat. Struct. Biol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="957" to="959" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">In silico screening-based discovery of inhibitors against glycosylation proteins dysregulated in cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R S</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J B</forename><surname>Grijaldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Nacario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Rabajante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Heralde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Lebrilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Completo</surname></persName>
		</author>
		<idno type="DOI">10.1080/07391102.2021.2022534</idno>
		<ptr target="https://doi.org/10.1080/07391102.2021.2022534" />
	</analytic>
	<monogr>
		<title level="j">J. Biomol. Struct. Dyn</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1540" to="1552" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Huey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Lindstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Sanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Belew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Goodsell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Olson</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcc.21256</idno>
		<ptr target="https://doi.org/10.1002/jcc.21256" />
	</analytic>
	<monogr>
		<title level="j">J. Comput. Chem</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="2785" to="2791" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Hanwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Lonie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vandermeersch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zurek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Hutchison</surname></persName>
		</author>
		<idno type="DOI">10.1186/1758-2946-4-17</idno>
		<ptr target="https://doi.org/10.1186/1758-2946-4-17" />
	</analytic>
	<monogr>
		<title level="j">J. Chem</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">17</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Open Babel: an open chemical toolbox</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>O'boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Banck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vandermeersch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Hutchison</surname></persName>
		</author>
		<idno type="DOI">10.1186/1758-2946-3-33</idno>
		<ptr target="https://doi.org/10.1186/1758-2946-3-33" />
	</analytic>
	<monogr>
		<title level="j">J. Chem</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">33</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings</title>
		<author>
			<persName><forename type="first">J</forename><surname>Eberhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Santos-Martins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Tillack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Forli</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jcim.1c00203</idno>
		<ptr target="https://doi.org/10.1021/acs.jcim.1c00203" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="3891" to="3898" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</title>
		<author>
			<persName><forename type="first">O</forename><surname>Trott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Olson</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcc.21334</idno>
		<ptr target="https://doi.org/10.1002/jcc.21334" />
	</analytic>
	<monogr>
		<title level="j">J. Comput. Chem</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="455" to="461" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">DocVSP (docking-based virtual screening Perlscript) for automating and integrating AutoDock and SBDD</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chauhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Srivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.52458/978-93-91842-08-6-28</idno>
		<ptr target="https://doi.org/10.52458/978-93-91842-08-6-28" />
	</analytic>
	<monogr>
		<title level="m">SCRS Conference Proceedings on Intelligent Systems</title>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="page" from="287" to="291" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">UCSF Chimera-a visualization system for exploratory research and analysis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Pettersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Goddard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Greenblatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Ferrin</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcc.20084</idno>
		<ptr target="https://doi.org/10.1002/jcc" />
	</analytic>
	<monogr>
		<title level="j">J. Comput. Chem</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1605" to="1612" />
			<date type="published" when="2004">2004. 20084</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">PlayMolecule ProteinPrepare: a web application for protein preparation for molecular dynamics simulations</title>
		<author>
			<persName><forename type="first">G</forename><surname>Martínez-Rosell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Giorgino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">De</forename><surname>Fabritiis</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jcim.7b00190</idno>
		<ptr target="https://doi.org/10.1021/acs.jcim.7b00190" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1511" to="1516" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Simmerling, ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kasavajhala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wickstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="DOI">10.1021/acs.jctc.5b00255</idno>
		<ptr target="https://doi.org/10.1021/acs.jctc.5b00255" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Theory Comput</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3696" to="3713" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Development and testing of a general amber force field</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Caldwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Kollman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Case</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcc.20035</idno>
		<ptr target="https://doi.org/10.1002/jcc.20035" />
	</analytic>
	<monogr>
		<title level="j">J. Comput. Chem</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1157" to="1174" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Rational design of particle mesh Ewald compatible Lennard-Jones parameters for +2 metal cations in explicit solvent</title>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Chakravorty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Merz</surname><genName>Jr</genName></persName>
		</author>
		<idno type="DOI">10.1021/ct400146w</idno>
		<ptr target="https://doi.org/10.1021/ct400146w" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Theory Comput</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="2733" to="2748" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Carbon dioxide binding to human carbonic anhydrase II</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Merz</surname><genName>Jr</genName></persName>
		</author>
		<idno type="DOI">10.1021/ja00002a004</idno>
		<ptr target="https://doi.org/10.1021/ja00002a004" />
	</analytic>
	<monogr>
		<title level="j">J. Am. Chem. Soc</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="406" to="411" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Structural survey of zinc-containing proteins and development of the zinc AMBER force field (ZAFF)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fusti-Molnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Merz</surname><genName>Jr</genName></persName>
		</author>
		<idno type="DOI">10.1021/ct1002626</idno>
		<ptr target="https://doi.org/10.1021/ct1002626" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Theory Comput</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="2935" to="2947" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jakalian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Jack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Bayly</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcc.10128</idno>
		<ptr target="https://doi.org/10.1002/jcc.10128" />
	</analytic>
	<monogr>
		<title level="j">J. Comput. Chem</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1623" to="1641" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Automatic atom type and bond type perception in molecular mechanical calculations</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Kollman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Case</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmgm.2005.12.005</idno>
		<ptr target="https://doi.org/10.1016/j.jmgm.2005.12.005" />
	</analytic>
	<monogr>
		<title level="j">J. Mol. Graph. Model</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="247" to="260" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">A modified TIP3P water potential for simulation with Ewald summation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename></persName>
		</author>
		<idno type="DOI">10.1063/1.1808117</idno>
		<ptr target="https://doi.org/10.1063/1.1808117" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Phys</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="10096" to="10103" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kräutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Van Gunsteren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Hünenberger</surname></persName>
		</author>
		<idno type="DOI">10.1002/1096-987X(20010415)22:5&lt;501::AID-JCC1021&gt;3.0.CO;2-V</idno>
		<ptr target="https://doi.org/10.1002/1096-987X" />
	</analytic>
	<monogr>
		<title level="j">J. Comput. Chem</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="501" to="508" />
			<date type="published" when="2001">2001. 20010415</date>
		</imprint>
	</monogr>
	<note>5&lt;501::AID-JCC1021&gt;3.0.CO;2-V</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N′-methylamide</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Loncharich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Pastor</surname></persName>
		</author>
		<idno type="DOI">10.1002/bip.360320508</idno>
		<ptr target="https://doi.org/10.1002/bip.360320508" />
	</analytic>
	<monogr>
		<title level="j">Biopolym. Orig. Res. Biomol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="523" to="535" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">An analysis of the accuracy of Langevin and molecular dynamics algorithms</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Pastor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Szabo</surname></persName>
		</author>
		<idno type="DOI">10.1080/00268978800101881</idno>
		<ptr target="https://doi.org/10.1080/00268978800101881" />
	</analytic>
	<monogr>
		<title level="j">Mol. Phys</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1409" to="1419" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Particle mesh Ewald: an N⋅log (N) method for Ewald sums in large systems</title>
		<author>
			<persName><forename type="first">T</forename><surname>Darden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>York</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pedersen</surname></persName>
		</author>
		<idno type="DOI">10.1063/1.464397</idno>
		<ptr target="https://doi.org/10.1063/1.464397" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Phys</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="10089" to="10092" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Investigating specificity of the anti-hypertensive inhibitor WNK463 against With-No-Lysine kinase family isoforms via multiscale simulations</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Jonniya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kar</surname></persName>
		</author>
		<idno type="DOI">10.1080/07391102.2019.1602079</idno>
		<ptr target="https://doi.org/10.1080/07391102" />
	</analytic>
	<monogr>
		<title level="j">J. Biomol. Struct. Dyn</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1306" to="1321" />
			<date type="published" when="2019">2019. 2019.1602079</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Kollman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Massova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Reyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1021/ar000033j</idno>
		<ptr target="https://doi.org/10.1021/ar000033j" />
	</analytic>
	<monogr>
		<title level="j">Acc. Chem. Res</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="889" to="897" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Investigating the mechanism of recognition and structural dynamics of nucleoprotein-RNA complex from Peste des petits ruminants virus via Gaussian accelerated molecular dynamics simulations</title>
		<author>
			<persName><forename type="first">R</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Poddar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nayak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kar</surname></persName>
		</author>
		<idno type="DOI">10.1080/07391102.2020.1838327</idno>
		<ptr target="https://doi.org/10.1080/07391102.2020.1838327" />
	</analytic>
	<monogr>
		<title level="j">J. Biomol. Struct. Dyn</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="2302" to="2315" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Structure and mechanism of DHHC protein acyltransferases</title>
		<author>
			<persName><forename type="first">R</forename><surname>Stix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Faraldo-Gómez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmb.2020.05.023</idno>
		<ptr target="https://doi.org/10.1016/j.jmb.2020.05.023" />
	</analytic>
	<monogr>
		<title level="j">J. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">432</biblScope>
			<biblScope unit="page" from="4983" to="4998" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">On the mechanism of protein palmitoylation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E P</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ungermann</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.embor.7400277</idno>
		<ptr target="https://doi.org/10.1038/sj.embor.7400277" />
	</analytic>
	<monogr>
		<title level="j">EMBO Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1053" to="1057" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.7150/ijbs.64046</idno>
		<ptr target="https://doi.org/10.7150/ijbs.64046" />
	</analytic>
	<monogr>
		<title level="j">Int. J. Biol. Sci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="4223" to="4237" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">In situ global proteomics profiling of EGCG targets using a cell-permeable and click-able bioorthogonal probe</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sahadevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Binoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Vechalapu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nanjan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sadhukhan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijbiomac.2023.123991</idno>
		<ptr target="https://doi.org/10.1016/j.ijbiomac.2023.123991" />
	</analytic>
	<monogr>
		<title level="j">Int. J. Biol. Macromol</title>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="page">123991</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Elias</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.abb.2010.06.013</idno>
		<ptr target="https://doi.org/10.1016/j.abb.2010.06.013" />
	</analytic>
	<monogr>
		<title level="j">Arch. Biochem. Biophys</title>
		<imprint>
			<biblScope unit="volume">501</biblScope>
			<biblScope unit="page" from="65" to="72" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Prooxidant effects of epigallocatechin-3-gallate in health benefits and potential adverse effect</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ouyang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1155/2020/9723686</idno>
		<ptr target="https://doi.org/10.1155/2020/9723686" />
	</analytic>
	<monogr>
		<title level="j">Oxid. Med. Cell. Longev</title>
		<imprint>
			<biblScope unit="volume">2020</biblScope>
			<biblScope unit="page">9723686</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Ligand chain length drives activation of lipid G protein-coupled receptors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Troupiotis-Tsaïlaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>González-Gil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ortega-Gutiérrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>López-Rodríguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Govaerts</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-017-02104-5</idno>
		<ptr target="https://doi.org/10.1038/s41598-017-02104-5" />
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">2020</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Palmitoylation: a protein S-acylation with implications for breast cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ragan</surname></persName>
		</author>
		<idno type="DOI">10.1038/npjbcancer.2016.28</idno>
		<ptr target="https://doi.org/10.1038/npjbcancer.2016.28" />
	</analytic>
	<monogr>
		<title level="j">NPJ Breast Cancer</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">16028</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Protein palmitoylation in cancer: molecular functions and therapeutic potential</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kong</surname></persName>
		</author>
		<idno type="DOI">10.1002/1878-0261.13308</idno>
		<ptr target="https://doi.org/10.1002/1878-0261.13308" />
	</analytic>
	<monogr>
		<title level="j">Mol. Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="3" to="26" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Submicromolar concentrations of palmitoyl-CoA specifically thioesterify cysteine 244 in glyceraldehyde-3-phosphate dehydrogenase inhibiting enzyme activity: a novel mechanism potentially underlying fatty acid induced insulin resistance</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Gross</surname></persName>
		</author>
		<idno type="DOI">10.1021/bi0508082</idno>
		<ptr target="https://doi.org/10.1021/bi0508082" />
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">35</biblScope>
			<biblScope unit="page" from="11903" to="11912" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Roe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Cheatham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename></persName>
		</author>
		<idno type="DOI">10.1021/ct400341p</idno>
		<ptr target="https://doi.org/10.1021/ct400341p" />
	</analytic>
	<monogr>
		<title level="j">J. Chem. Theory Comput</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3084" to="3095" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Rapid and selective detection of fatty acylated proteins using omega-alkynyl-fatty acids and click chemistry</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kostiuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Perinpanayagam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Hak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Siddam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Majjigapu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rajaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Prescher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1194/jlr.D002790</idno>
		<ptr target="https://doi.org/10.1194/jlr.D002790" />
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1566" to="1580" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
